ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
'Most Promising' Cardioprotective Strategy Ends Up a Bust
Tuesday, September 3, 2019
Submitted by
Source
Source Name: MadPage Today
Remote ischemic preconditioning did not influence 12-month survival or readmission rates in a randomized trial involving more than 5,400 patients undergoing percutaneous coronary intervention after ST-segment elevation MI.
Printer-friendly
